Recurrent gene fusions in cancer
US9783853B2 · kind B2 · utility
1Cited by
0References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 11, 2014 |
| Grant date | Oct 10, 2017 |
| Priority date | — |
| Expiry date | Feb 17, 2035 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/71
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present disclosure relates to compositions and methods for cancer diagnosis, research and therapy, including but not limited to, cancer markers. In particular, the present disclosure relates to gene fusions as diagnostic markers and clinical targets for cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.